Fidelity Investments
CMTA

Fidelity Investments’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Fidelity Investments’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-500,000
Closed -$6.58M – 3907
2018
Q2 		$6.58M Hold
500,000
– – ﹤0.01% 2072
2018
Q1 		$7.58M Hold
500,000
– – ﹤0.01% 2032
2017
Q4 		$9.49M Hold
500,000
– – ﹤0.01% 1970
2017
Q3 		$8.45M Buy
+500,000
New +$8.17M ﹤0.01% 2001

Other funds holding CMTA

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return